Canadian biotech Eyam Health has entered a research alliance with Swiss-based nonprofit Medicines for Malaria Venture to ...

Shares in Sarepta Therapeutics have slumped by more than a third since late last week amid new updates on its gene therapy ...

The US regulator has tapped Stanford University physician-scientist and former biotech executive George Tidmarsh to serve as ...

Adding to the string of US and international drugmakers investment in US production investment following a call from ...

The Association of the British Pharmaceutical Industry (ABPI) has appointed Laura McMullin as vice president of the trade ...

French pharma major Sanofi today announced it has entered into an agreement to acquire Vicebio, a privately held biotechnology company headquartered in London, UK.

George Medicines, a UK biopharma focused on cardiometabolic diseases, has entered into an exclusive licensing and supply ...

US biotech major Biogen has announced that it intends to invest an additional $2 billion in its existing manufacturing ...

NodThera, a privately-held biotech working in chronic inflammatory diseases through selective modulation of the NLRP3 ...

The US Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application (sNDA) for Sotyktu ...

South Korea’s biosimilar drug developer Samsung Bioepis today released its Third Quarter 2025 Market Report, marking the ...

Positive high-level results have been presented from the final overall survival (OS) analysis of the FLAURA2 Phase III trial.